Abstract
Cisplatin (DDP) was a commonly used drug in the treatment of nonsmall cell lung cancer (NSCLC). However, the current resistance of patients to DDP ser......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
